Current Issues in the Diagnosis and Treatment of Endometrial Carcinoma

Overview

Journal Geburtshilfe Frauenheilkd

Specialty Gynecology & Obstetrics

Date 2016 Mar 5

PMID 26941450

Citations 11

Authors

J Stubert

B Gerber

Affiliations

Soon will be listed here.

Abstract

Endometrial carcinoma is the most common carcinoma of the female genital tract. Its most important clinical sign is postmenopausal bleeding. An endometrial biopsy is essential for diagnosis. Treatment decisions are governed by tumour risk assessment and patient comorbidity, which is often present. Pelvic and paraaortic lymph node dissection is unnecessary in low risk cases (definition: pT1 a, G1/2) and adjuvant radiotherapy and systemic treatments are usually avoidable. Treatment of high-risk patients (G3 and/or pT1b) and palliative cases is difficult and not well standardised. New molecular-based subtype classification may help treatment decision making in future.

Citing Articles

The da Vinci robotic surgery system for the management of endometrial cancer: a single-center experience.

Latifah H, Khan M, Nadreen F, Latifah A, Asaad A, Baradwan S J Robot Surg. 2024; 18(1):89.

PMID: 38386227 DOI: 10.1007/s11701-024-01845-6.

A prognostic model and immune regulation analysis of uterine corpus endometrial carcinoma based on cellular senescence.

Gao L, Wang X, Wang X, Wang F, Tang J, Ji J Front Oncol. 2022; 12:1054564.

PMID: 36568182 PMC: 9775865. DOI: 10.3389/fonc.2022.1054564.

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis.

Winarto H, Ibrahim N, Putri Y, Adnan F, Safitri E PeerJ. 2022; 10:e14420.

PMID: 36438578 PMC: 9695495. DOI: 10.7717/peerj.14420.

Prognosis and Efficacy of Laparoscopic Surgery on Patients with Endometrial Carcinoma: Systematic Evaluation and Meta-Analysis.

Ma J, Zhou C, Chen J, Chen X Comput Math Methods Med. 2022; 2022:9384134.

PMID: 36238475 PMC: 9553337. DOI: 10.1155/2022/9384134.

miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.

Lu X, Jing L, Liu S, Wang H, Chen B Int J Endocrinol. 2022; 2022:5006123.

PMID: 35719192 PMC: 9200575. DOI: 10.1155/2022/5006123.

References

Kitchener H, Swart A, Qian Q, Amos C, Parmar M . Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2008; 373(9658):125-36. PMC: 2646126. DOI: 10.1016/S0140-6736(08)61766-3. View

Benedetti Panici P, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G . Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100(23):1707-16. DOI: 10.1093/jnci/djn397. View

Zuber T . Endometrial biopsy. Am Fam Physician. 2001; 63(6):1131-5, 1137-41. View

Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A . Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2010; 12(1):38-48. DOI: 10.1016/S1470-2045(10)70268-0. View

Gallos I, Yap J, Rajkhowa M, Luesley D, Coomarasamy A, Gupta J . Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012; 207(4):266.e1-12. DOI: 10.1016/j.ajog.2012.08.011. View

Watanabe Y, Satou T, Nakai H, Etoh T, Dote K, Fujinami N . Evaluation of parametrial spread in endometrial carcinoma. Obstet Gynecol. 2010; 116(5):1027-34. DOI: 10.1097/AOG.0b013e3181f80a49. View

Kurman R, Kaminski P, NORRIS H . The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985; 56(2):403-12. DOI: 10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x. View

Murali R, Soslow R, Weigelt B . Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014; 15(7):e268-78. DOI: 10.1016/S1470-2045(13)70591-6. View

Lelle R, Morley G, Peters W . The role of vaginal hysterectomy in the treatment of endometrial carcinoma. Int J Gynecol Cancer. 1994; 4(5):342-347. DOI: 10.1046/j.1525-1438.1994.04050342.x. View

10.

Emons G, Beckmann M, Schmidt D, Mallmann P . New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015; 75(2):135-136. PMC: 4361167. DOI: 10.1055/s-0034-1396256. View

11.

Seebacher V, Schmid M, Polterauer S, Hefler-Frischmuth K, Leipold H, Concin N . The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer. 2009; 9:460. PMC: 2807879. DOI: 10.1186/1471-2407-9-460. View

12.

Suh-Burgmann E, Hung Y, Armstrong M . Complex atypical endometrial hyperplasia: the risk of unrecognized adenocarcinoma and value of preoperative dilation and curettage. Obstet Gynecol. 2009; 114(3):523-529. DOI: 10.1097/AOG.0b013e3181b190d5. View

13.

Carlson M, Thiel K, Leslie K . Past, present, and future of hormonal therapy in recurrent endometrial cancer. Int J Womens Health. 2014; 6:429-35. PMC: 4014387. DOI: 10.2147/IJWH.S40942. View

14.

Vergote I, Amant F, Timmerman D . Should we screen for endometrial cancer?. Lancet Oncol. 2010; 12(1):4-5. DOI: 10.1016/S1470-2045(10)70280-1. View

15.

Gallos I, Shehmar M, Thangaratinam S, Papapostolou T, Coomarasamy A, Gupta J . Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010; 203(6):547.e1-10. DOI: 10.1016/j.ajog.2010.07.037. View

16.

Pectasides D, Pectasides E, Economopoulos T . Systemic therapy in metastatic or recurrent endometrial cancer. Cancer Treat Rev. 2007; 33(2):177-90. DOI: 10.1016/j.ctrv.2006.10.007. View

17.

Barak F, Kalichman L, Gdalevich M, Milgrom R, Laitman Y, Piura B . The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival. Arch Gynecol Obstet. 2013; 288(6):1361-4. DOI: 10.1007/s00404-013-2898-5. View

18.

Horwitz R, Feinstein A, Horwitz S, Robboy S . Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies. Lancet. 1981; 2(8237):66-8. DOI: 10.1016/s0140-6736(81)90412-8. View

19.

Bell J, Patterson D, Klima J, Harvison M, Rath K, Reid G . Outcomes of patients with low-risk endometrial cancer surgically staged without lymphadenectomy based on intra-operative evaluation. Gynecol Oncol. 2014; 134(3):505-9. DOI: 10.1016/j.ygyno.2014.06.028. View

20.

Nout R, Smit V, Putter H, Jurgenliemk-Schulz I, Jobsen J, Lutgens L . Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010; 375(9717):816-23. DOI: 10.1016/S0140-6736(09)62163-2. View